ACM Research (ACMR) UBS Global Technology and AI Conference summary
Event summary combining transcript, slides, and related documents.
UBS Global Technology and AI Conference summary
11 Jan, 2026Impact of export controls and supply chain localization
Recent export controls added many Chinese equipment firms to the entity list, creating new supply chain challenges, but no specific wrongdoing was cited.
The company has localized much of its supply chain, reducing U.S. dependency, and expects to manage through new restrictions.
Domestic Chinese chipmakers face strong incentives to localize equipment sourcing, driven by regulations and proximity to fabs.
The push for domestic sourcing is expected to continue, with the company aiming to win business on product merit rather than policy.
Market outlook and growth strategy
China WFE spending is expected to decline in 2025, partly due to pre-purchasing in 2024, but the company anticipates continued growth from market share gains.
International business remains a small revenue contributor but is targeted for expansion.
A $3 billion long-term revenue target is split evenly between China and international markets, based on market share goals and a $30 billion China WFE market.
Expansion efforts include new R&D and demo facilities in Oregon and increased headcount in Korea.
Product innovation and competitive positioning
Cleaning tools represent over 70% of revenue, with a broad product offering covering 90% of cleaning steps.
The Tahoe tool breakthrough reduces sulfuric acid consumption by 75% at advanced nodes, offering ESG benefits and competitive performance.
Furnace tools are in evaluation, with meaningful revenue expected in 2025.
Plating (ECP) tools, especially for advanced packaging, are a growing focus, with three new panel-level products recently announced.
The company faces strong competition from larger players in each product area but aims to differentiate through innovation.
Latest events from ACM Research
- 2025 revenue hit $901.3M, with 2026 guidance for 21–30% growth despite margin pressure.ACMR
Q4 202526 Feb 2026 - Q2 revenue up 40% to $202.5M, margins strong, 2024 guidance raised, new products launched.ACMR
Q2 20242 Feb 2026 - Q3 revenue up 21% to $204M, margins strong, 2024 outlook raised, global expansion ongoing.ACMR
Q3 202416 Jan 2026 - 2024 revenue rose 40% to $782.1M, with strong margins and a robust 2025 outlook.ACMR
Q4 202423 Dec 2025 - Shareholders will elect four directors and ratify the auditor at a virtual 2025 annual meeting.ACMR
Proxy Filing1 Dec 2025 - Election of directors and auditor ratification to be decided at the June 2025 virtual meeting.ACMR
Proxy Filing1 Dec 2025 - Q1 2025 revenue up 13.2% year-over-year, with net income and cash rising but margin lower.ACMR
Q1 202525 Nov 2025 - Q2 2025 revenue grew 6.4% to $215.4M, with margin gains and robust global expansion outlook.ACMR
Q2 202523 Nov 2025 - Q3 2025 revenue up 32% to $269.2M; margin pressure and trade risks remain.ACMR
Q3 202513 Nov 2025